Mergers and Acquisitions Recap: Avon Issue Over, DuPont Hates Car Paint
ING’s (NYSE:ING) Asian asset management division is reported to have a list of suitors, that include Macquarie Group (MQBKY.PK), Principal Financial Group (NYSE:PFG) and Singapore’s United Overseas...
View ArticleHealthcare Biz Recap: Aeterna Zentaris Shares Surge, J&J Files with FDA
Shares of Aeterna Zentaris (NASDAQ:AEZS) pop on the news of an article that describes how the firm’s perifosine compound might be used to treat Malignant Pleural Mesothelioma, which is an aggressive...
View ArticleEquity Insights June 1st: Ameresco, Augme Technologies, Intel, Amylin, Joy...
Ameresco, Inc. (NYSE:AMRC): Oppenheimer notes that Amerseco’s awarded backlogs and new proposals have increased by double digits. The firm expects the company’s revenue to increase by mid-teens levels...
View ArticleAnalyst Alerts: Johnson & Johnson, Harley-Davidson, Nuance, Amylin, Guess...
Johnson & Johnson (NYSE:JNJ): Bernstein expects the recent product launches by Johnson & Johnson’s pharmaceutical unit to cause the unit’s growth to accelerate. The firm believes that the...
View ArticleHealthcare Biz Recap: Henry Schein and Masimo POP, Questcor Reveals Comments
Shares of both Henry Schein (NASDAQ:HSIC) and its new partner Masimo Corporation (NASDAQ:MASI) move higher, as they announce an agreement in which the former will distribute the latter’s Masimo’s...
View ArticleHealthcare Biz Recap: Amylin in FDA HOT WATER, Rosetta Genomics OFFERS Up Shares
Amylin (NASDAQ:AMLN) could be in serious trouble with the FDA, as it’s accused of covering up a study of its Byetta diabetes med, that raised concerns over heart safety, and then putting the agency off...
View ArticleWall St. Brief: Barclays Chairman RESIGNS, Bristol-Myers Makes HUGE Acquisition
Barclays (NYSE:BCS) Chairman Marcus Agius has resigned in light of the Libor scandal; upon exiting, he said, “the buck stops with me.” But the pressure continues for the bank’s CEO, Bob Diamond, to...
View ArticleAfternoon BUZZERS: Dell and Bristol Play Dealmakers, Facebook’s FIRM Decision
Shares of Barclays PLC (NYSE:BCS) have gained 4.17 percent as of this afternoon. The bank’s Chairman Marcus Agius quit on Monday, saying that the recent Libor scandal was “a devastating blow” to...
View ArticleHealthcare Biz Recap: Glaxo TRICKS Doctors, Amylin BOUGHT By Two Firms
GlaxoSmithKline’s (NYSE:GSK) once-a-day lung medication LAMA/LABA performed well in late-stage testing in patients suffering from chronic obstructive pulmonary disease. Glaxo hopes that the drug will...
View ArticleHealthcare Biz Review: Osiris ACCUSED, Chelsea’s BAD NEWS
Osiris Therapeutics (NASDAQ:OSIR) stands accused by Adam Feuerstein at The Street of misleading its investors concerning the results from a Phase II trial of its stem-cell treatment Prochymal in...
View Article
